Measles (Rubeola) Antibody, IgG and IgM, Spinal Fluid
Measles (Rubeolla) virus is classified as a paramyxovirus that causes a highly contagious respiratory infection. Since the introduction of a measles virus vaccine in 1963, the disease has essentially been eliminated as a major childhood illness. In spite of the widespread vaccination programs, many individuals remain susceptible to measles as a result of primary vaccine failure or non-immunization.
Measles serology testing has become an increasingly important tool for determination of seroconversion following infection and assessment of immunity in vaccinated individuals. In addition, measles serology can be a valuable tool in the diagnosis of subacute sclerosing panencephalitis, which may occur years after the original measles infection.
- Diagnosis of measles (Rubeolla) infection
- Serological determination of immune status following vaccination or seroconversion following infection
- Assessment of measles serological status in pregnant women as linked to premature delivery or spontaneous abortion
Increased or Positive for Antibody (Detected) in:
- Recent infection, in past infections
- Vaccination (immunity)
- Congenital rubeolla infection
Negative for antibody (Not detected) in:
- Non-vaccinated patients or newborn and young children
- Not vaccinated or exposed to virus
Negative (Non-reactive)
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Cerebrospinal fluid collected in a sterile container.
Stability
- Ambient: 1-3 days
- Refrigerated: 3-5 days
- Frozen: 30 days
- Am J Infect Control. 1991 Dec;19(6):290-8. [PMID: 1763825]
- Clin Diagn Lab Immunol. 1999 Mar;6(2):178-80. [PMID: 10066650]
- J Infect Dis. 1997 Jan;175(1):195-9. [PMID: 8985220]
- J Infect Dis. 2003 May 15;187 Suppl 1:S283-90. [PMID: 12721927]
- Neuroscientist. 2011 Apr 29. [PMID: 21531984]